CA2233367A1 - Formes courtes de la chimiokine .beta.-8 - Google Patents

Formes courtes de la chimiokine .beta.-8 Download PDF

Info

Publication number
CA2233367A1
CA2233367A1 CA002233367A CA2233367A CA2233367A1 CA 2233367 A1 CA2233367 A1 CA 2233367A1 CA 002233367 A CA002233367 A CA 002233367A CA 2233367 A CA2233367 A CA 2233367A CA 2233367 A1 CA2233367 A1 CA 2233367A1
Authority
CA
Canada
Prior art keywords
polypeptide
cells
polypeptides
seq
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002233367A
Other languages
English (en)
Inventor
John White
Edward Appelbaum
Daniel O'shannessy
James Allan Fornwald
Kevin O'donnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002233367A priority Critical patent/CA2233367A1/fr
Publication of CA2233367A1 publication Critical patent/CA2233367A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

On décrit de nouveaux polypeptides relatifs à la forme tronquée de la Ck.beta.-8 humaine, ainsi que des procédés d'utilisation de ces polypeptides.
CA002233367A 1995-09-29 1996-09-27 Formes courtes de la chimiokine .beta.-8 Abandoned CA2233367A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002233367A CA2233367A1 (fr) 1995-09-29 1996-09-27 Formes courtes de la chimiokine .beta.-8

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/004,517 1995-09-29
CA002233367A CA2233367A1 (fr) 1995-09-29 1996-09-27 Formes courtes de la chimiokine .beta.-8

Publications (1)

Publication Number Publication Date
CA2233367A1 true CA2233367A1 (fr) 1997-04-03

Family

ID=4162255

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002233367A Abandoned CA2233367A1 (fr) 1995-09-29 1996-09-27 Formes courtes de la chimiokine .beta.-8

Country Status (1)

Country Link
CA (1) CA2233367A1 (fr)

Similar Documents

Publication Publication Date Title
EP0735818B1 (fr) PROTEINES INFLAMMATOIRES MACROPHAGES MIP-3, MIP-4 ET MIP-1gamma
US5504003A (en) Macrophage inflammatory protein-3 and -4
AU708903B2 (en) Human chemokine polypeptides
AU723891B2 (en) Human chemokine beta-11 and human chemokine alpha-1
CA2220123A1 (fr) Chimiokine beta-8, chimiokine beta-1 et proteine 4 inflammatoire des macrophages d'origine humaine
AU708558B2 (en) Human chemokine beta-9
EP0832233B1 (fr) Chemokine beta-13 humaine
CA2211003A1 (fr) Recepteur du facteur de necrose des tumeurs humain
IL135351A (en) RANTES is interrupted as an antagonist to Kamokin
EP0767796B1 (fr) Proteine chimiotactique
EP0811059A1 (fr) Chemokine humaine beta-11 et chemokine humaine alpha-1
AU711573B2 (en) Short forms of chemokine beta-8
PL204231B1 (pl) Zastosowanie mutanta chemokiny CC, kompozycja farmaceutyczna do leczenia stwardnienia rozsianego, skrócona i zmutowana ludzka RANTES i sposób jej wytwarzania, cząsteczka DNA i zawierający ją wektor ekspresyjny oraz komórka gospodarza
EP1458756A1 (fr) Mutants de chimiokines agissant en tant qu'antagonistes de chimiokines
US20030138400A1 (en) Short forms of chemokine beta-8
CA2233367A1 (fr) Formes courtes de la chimiokine .beta.-8
CN1198186U (zh) 趋化因子β－8的短形式
WO1998024907A1 (fr) Proteine a activite chemokine
JPH08140683A (ja) 新規な白血球活性化因子
MXPA98002380A (en) Short shapes of bet chemiscino
AU734252B2 (en) Novel mouse CXC chemokine receptor
KR100250090B1 (ko) 사람에서 분리한 c 6 베타-케모카인 lkn-2의 cdna 및재조합 lkn-2의 제조방법
AU753088B2 (en) Human chemokine polypeptides
JP2002320492A (ja) ヒトケモカインβ−１１およびヒトケモカインα−１
KR19990087164A (ko) 사람 케모킨 폴리펩티드

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued